Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has updated its version from v2.14.1 to v2.14.2 and removed older dates from January 2025, replacing them with new dates in February 2025.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated with new entries for January 2025, including a revision to v2.14.1, while previous updates from December 2024 have been removed.SummaryDifference0.5%
- Check66 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check95 days agoChange DetectedThe website has been updated to version 2.13.3, replacing the estimated last update with a definitive last update posted.SummaryDifference0.1%
- Check102 days agoChange DetectedThe website has updated the contact details section for the study, replacing the previous information with new details and indicating a revision to version 2.13.2.SummaryDifference1%
- Check117 days agoChange DetectedThe website has been updated from version 2.12.1 to 2.12.2.SummaryDifference0.0%
Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.